World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
34890
World Ranking
11209
National Ranking
5759

Overview

Alfred E. Chang is affiliated with the University of Michigan-Ann Arbor in the United States. Their research focuses primarily on the fields of Medicine and Psychology, with notable contributions to reproductive medicine and social psychology.

The main areas of study in their work include:

  • Medicine
  • Psychology

More specifically, their research engages several subfields such as:

  • Reproductive Medicine
  • Social Psychology
  • Immunology
  • Molecular Biology
  • Public Health, Environmental and Occupational Health

Chang's work often explores the following topics:

  • Ovarian function and disorders
  • LGBTQ Health, Identity, and Policy
  • Reproductive System and Pregnancy
  • Reproductive Biology and Fertility
  • Ovarian cancer diagnosis and treatment
  • Sexuality, Behavior, and Technology
  • Sexual Differentiation and Disorders

The scientist has published research in the following venues:

  • Reproduction
  • Human Reproduction
  • F&S Science
  • Biology of Reproduction
  • Fertility and Sterility

Some of the recent papers authored or co-authored by Alfred E. Chang include:

  • The ovarian stroma as a new frontier, 2020, Reproduction
  • A mouse model mimicking gender-affirming treatment with pubertal suppression followed by testosterone in transmasculine youth, 2022, Human Reproduction
  • Reversibility of testosterone-induced acyclicity after testosterone cessation in a transgender mouse model, 2021, F&S Science
  • Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model, 2023, Biology of Reproduction
  • REVERSIBILITY OF HORMONAL AND CYCLIC DISRUPTIONS IN A TRANSGENDER MOUSE MODEL AFTER CESSATION OF TESTOSTERONE THERAPY, 2020, Fertility and Sterility

The work frequently involves collaboration with several co-authors, including:

  • Hadrian M. Kinnear
  • Molly B. Moravek
  • Vasantha Padmanabhan
  • Ariella Shikanov
  • Prianka H. Hashim

Best Publications

  • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang

  • Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman

  • The National Cancer Data Base Report on Cutaneous and Noncutaneous Melanoma A Summary of 84,836 Cases from the Past Decade

    Alfred E. Chang;Lucy Hynds Karnell;Lucy Hynds Karnell;Herman R. Menck

  • Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

    James C. Yang;Alfred E. Chang;Alan R. Baker;William F. Sindelar

  • Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

    Gary J. Nabel;Elizabeth G. Nabel;Zhi Yong Yang;Bernard A. Fox

  • Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

    Ilona Kryczek;Mousumi Banerjee;Pui Cheng;Linhua Vatan

  • Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer

    Steven A. Rosenberg;Michael T. Lotze;James C. Yang;Suzanne L. Topalian

  • A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

    Alfred E. Chang;Philip D. Schneider;Paul H. Sugarbaker;Colleen Simpson

  • Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma

    Lowell A. Goldsmith;Frederic B. Askin;Alfred E. Chang;Cynthia Cohen

  • High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer: Responses, Treatment-Related Morbidity, and Histologic Findings

    Michael T. Lotze;Alfred E. Chang;Claudia A. Seipp;Colleen Simpson

  • The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

    Kirk D. Denicoff;David R. Rubinow;Moshe Z. Papa;Colleen Simpson

  • Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

    S L Topalian;D Solomon;F P Avis;A E Chang

  • Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

    P Piedbois;M Buyse;N Kemeny

  • Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment

    Ilona Kryczek;Shuang Wei;Linhua Zou;Saleh Altuwaijri

  • Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.

    Christina M. Coughlin;Kevin E. Salhany;Maria Wysocka;Etsuko Aruga

  • Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

    Guilian Niu;Tammy Bowman;Mei Huang;Steve Shivers

  • Diagnosis and treatment of early melanoma

    W. H. Hall;L. A. Goldsmith;F. B. Askin;A. E. Chang

  • Vaccination Of Pediatric Solid Tumor Patients with Tumor Lysate-pulsed Dendritic Cells Can Expand Specific T Cells and Mediate Tumor Regression

    James D. Geiger;Raymond J. Hutchinson;Lyndon F. Hohenkirk;Elizabeth A. McKenna

  • High‐grade soft tissue sarcomas of the extremities

    Dorothy A. Potter;Timothy Kinsella;Eli Glatstein;Robert Wesley

  • Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

    Vernon K. Sondak;Jeremy M. G. Taylor;Michael S. Sabel;Yue Wang

Frequent Co-Authors

Max S. Wicha
Max S. Wicha University of Michigan–Ann Arbor
Vernon K. Sondak
Vernon K. Sondak University of South Florida
Suyu Shu
Suyu Shu University of Michigan–Ann Arbor
Lisa A. Newman
Lisa A. Newman Cornell University
Kent A. Griffith
Kent A. Griffith University of Michigan–Ann Arbor
Timothy M. Johnson
Timothy M. Johnson University of Michigan–Ann Arbor
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Celina G. Kleer
Celina G. Kleer University of Michigan–Ann Arbor
Elizabeth G. Nabel
Elizabeth G. Nabel Brigham and Women's Hospital
Mark A. Helvie
Mark A. Helvie University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medical careers beyond the MD track? There are a range of flexible online degree options that support alternative pathways in healthcare. These programs cater to those seeking specialized roles or wishing to upskill for career advancement, often providing greater accessibility and affordability compared to traditional in-person degrees.

For example, pharmacy professionals can now pursue online pharmd programs, which offer advanced clinical and leadership training. Those interested in healthcare informatics might explore an online mhi degree to enter the rapidly growing field of health information management.

Entry-level positions, such as medical billing and coding specialists, are also attainable through targeted training like online medical billing and coding courses. Additionally, nurses aiming to advance can find affordable options among the cheapest np school online to earn their nurse practitioner credentials.

These programs make healthcare education more inclusive, allowing students to balance studies with work or family commitments—opening up a diverse array of rewarding clinical and non-clinical career paths in medicine.

Best Scientists Citing Alfred E. Chang

Trending Scientists